You are here
Home 🌿 Medical Cannabis News 🌿 Cannabis-based drug to be made available to NSW children 🌿Cannabis-based drug to be made available to NSW children
A small number of children with drug-resistant epilepsy will soon be able to access a new cannabis-based drug in New South Wales which is showing promise in relieving the symptoms.
The pharmaceutical drug, Epidolex, is still in a trial phase and has not yet received full approval from authorities, but the Government has now set the date of March for a compassionate access scheme to begin.
Last year, the NSW Government approached the company that makes the drug, the UK's GW Pharmaceuticals, to see if trials could be arranged in NSW.
Pru Goward, the Minister for Medical Research, said the scheme was great news for families who had children with the condition.
"These families are desperate," Ms Goward told the ABC.
This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.
420 Intel is Your Source for Marijuana News
420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.
420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.
Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.
You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.